The Relationship Between Hemoglobin A1c, Time in Range, and Glycemic Management Indicator in Patients With Type 1 and Type 2 Diabetes in a Tertiary Care Hospital in Saudi Arabia.

diabetes flash glucose monitoring glycemia management indicator hypoglycemia time in range

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Jul 2024
Historique:
accepted: 29 06 2024
medline: 6 8 2024
pubmed: 6 8 2024
entrez: 6 8 2024
Statut: epublish

Résumé

This study aimed to assess the correlation between glycated hemoglobin A1 (HbA1c), time in range (TIR), and glycemic management indicator (GMI) in patients with both type 1 diabetes (T1D) and type 2 diabetes (T2D) who were using a flash glucose monitoring (FGM) device (FreeStyle Libre; Abbott Diabetic Care, Witney, UK). This was a retrospective study that looked at T1D and T2D FreeStyle Libre users' LibreView database in the period between January 2020 to June 2022. The study was conducted at the diabetes department at the King Fahad Medical City (KFMC) in Riyadh, Saudi Arabia, following Institutional Review Board (IRB) approval. Data were collected from the LibreView website, as well as from the electronic privacy information center (EPIC) hospital records. Data were available for 327 patients, mean age of 33.08(±17.1) years old, and 55.7% were females. HbA1c had a statistically significant correlation with both TIR and GMI with coefficient of correlation (r) values of 0.78 (p<0.001) and 0.82 (p<0.001), respectively. A linear regression model between TIR and Hb1Ac was also developed and found to be statistically significant (p<0.001) with an acceptable R Study findings revealed that the %TIR could be a reliable predictor of Hb1Ac. Thus, Freestyle Libre was able to determine Hb1Ac as close to the lab results as possible. Therefore, it is necessary to encourage diabetes patients to achieve at least 70% TIR in order to keep Hb1Ac within the desired range.

Identifiants

pubmed: 39105008
doi: 10.7759/cureus.63947
pmc: PMC11299043
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e63947

Informations de copyright

Copyright © 2024, Alazmi et al.

Déclaration de conflit d'intérêts

Human subjects: Consent was obtained or waived by all participants in this study. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: This study was funded by a research grant from the center in the King Fahad Medical City - Riyadh, Intramural Research Fund (IRF), approval no. # 022-034. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Auteurs

Ahmed A Alazmi (AA)

Obesity, Endocrine, and Metabolism Center, King Fahad Medical City, Riyadh, SAU.
Family Medicine and Endocrine Department, King Fahad Specialist Hospital, Dammam, SAU.

Imad Brema (I)

Obesity, Endocrine, and Metabolism Center, King Fahad Medical City, Riyadh, SAU.
College of Medicine, Alfaisal University, Riyadh, SAU.

Saad H Alzahrani (SH)

Obesity, Endocrine, and Metabolism Center, King Fahad Medical City, Riyadh, SAU.

Mohammed S Almehthel (MS)

Obesity, Endocrine, and Metabolism Center, King Fahad Medical City, Riyadh, SAU.
Division of Endocrinology, University of British Columbia, Vancouver, CAN.

Classifications MeSH